International Genetic Obesity Registry

计划入组 5,000 人 · 首次发布于 2025 年 12 月 22 日

Characterization of Transcriptional Regulators of Ghrelin Hormone Which Causes Genetic Obesity

计划入组 58 人 · 首次发布于 2011 年 7 月 28 日

Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity

计划入组 200 人 · 首次发布于 2026 年 6 月 29 日

Obesity therapeutic

Obesity exosome

Obesity(Abalone)

Genetic Immunity

United States

Genetic Technologies Ltd

SHIRE HUMAN GENETIC THERAPIES, INC.

United States

Congruence Therapeutics Advances CGX-926 for Rare Genetic Obesity as Company Presents Novel MC4R Corrector Data

Dietary Intervention Reduces BMI Regardless of Genetic Obesity Risk, Clinical Trial Finds

Superluminal Medicines Raises $60M Series B to Advance MC4R Agonist for Rare Genetic Obesity into the Clinic